5-MEO-DMT developer GH Research has provided an update on its main clinical programs. The company is notoriously short on communications outside of the...
–Topline efficacy data expected in Q4 2023 – – Preparations are underway to scale the CYB003 program to a potential Phase 3 study in early 2024...
The two companies also shared next steps in their drug testing regimens. The post Atai, Cybin Give Positive Psychedelic Drug Study Updates appeared first...
Atai Life Sciences has completed its Phase 1 study of VLS-01, an oral DMT for treatment-resistant depression (TRD). The post atai Life Sciences Completes...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Osaka, Japan – Circadian rhythms, the internal biological clocks that regulate our daily activities, are essential for maintaining health and well-being....
If you dive deep into the underground psychedelic scene, you are bound to encounter some creative theories about aliens. Aliens and psychedelics seem to...
A Michigan lawmaker has relaunched efforts to legalize psychedelic fungi and plants with the caveat that all psychedelic-related activity does not involve...
The study found that 100 per cent of patients were responsive and 92 per cent went into remission The post Antidepressants enhance DMT efficacy in patients...
The DMT drug appeared more effective when combined with SSRIs. The post Small Pharma Sees Promise Pairing DMT Drug with Antidepressants appeared first...